Evidence map›Paper›PMID 24255110›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Design and formulation of functional pluripotent stem cell-derived cardiac microtissues.

Nimalan Thavandiran, Nicole Dubois, Alexander Mikryukov, Stéphane Massé, Bogdan Beca, Craig A Simmons, Vikram S Deshpande, J Patrick McGarry, Christopher S Chen, Kumaraswamy Nanthakumar and 3 more

Erratum issuedAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 164 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
164citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

164 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Engineering the maturation of stem cell-derived cardiomyocytes.Frontiers in bioengineering and biotechnology · 2023
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Organs on chips: fundamentals, bioengineering and applications.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Application of human cardiac organoids in cardiovascular disease research.Frontiers in cell and developmental biology · 2025
    Review
  20. Review

104 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Nimalan ThavandiranInstitute for Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada M5S 3G9.
Nicole Dubois
Alexander Mikryukov
Stéphane Massé
Bogdan Beca
Craig A Simmons
Vikram S Deshpande
J Patrick McGarry
Christopher S Chen
Kumaraswamy Nanthakumar
Gordon M Keller
Milica Radisic
Peter W Zandstra

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Access to robust and information-rich human cardiac tissue models would accelerate drug-based strategies for treating heart disease. Despite significant effort, the generation of high-fidelity adult-like human cardiac tissue analogs remains challenging. We used computational modeling of tissue contraction and assembly mechanics in conjunction with microfabricated constraints to guide the design of aligned and functional 3D human pluripotent stem cell (hPSC)-derived cardiac microtissues that we term cardiac microwires (CMWs). Miniaturization of the platform circumvented the need for tissue vascularization and enabled higher-throughput image-based analysis of CMW drug responsiveness. CMW tissue properties could be tuned using electromechanical stimuli and cell composition. Specifically, controlling self-assembly of 3D tissues in aligned collagen, and pacing with point stimulation electrodes, were found to promote cardiac maturation-associated gene expression and in vivo-like electrical signal propagation. Furthermore, screening a range of hPSC-derived cardiac cell ratios identified that 75% NKX2 Homeobox 5 (NKX2-5)+ cardiomyocytes and 25% Cluster of Differentiation 90 OR (CD90)+ nonmyocytes optimized tissue remodeling dynamics and yielded enhanced structural and functional properties. Finally, we demonstrate the utility of the optimized platform in a tachycardic model of arrhythmogenesis, an aspect of cardiac electrophysiology not previously recapitulated in 3D in vitro hPSC-derived cardiac microtissue models. The design criteria identified with our CMW platform should accelerate the development of predictive in vitro assays of human heart tissue function.

Indexed as

Biomechanical PhenomenaCellular MicroenvironmentElectric StimulationFinite Element AnalysisHomeobox Protein Nkx-2.5Homeodomain ProteinsHumansMyocardiumPluripotent Stem CellsThy-1 AntigensTissue EngineeringTranscription FactorsHomeobox Protein Nkx-2.5Homeodomain ProteinsNKX2-5 protein, humanThy-1 AntigensTranscription Factorsarrhythmia disease modelcardiac toxicityheart regenerationmicrofabricationtissue engineering

Identifiers

PMID24255110
PMCPMC3856835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.